Table1 Baseline characteristics of individual studies and patients
First Author | Year | Region | Study time | Patients | Follow-up time | Age (Years) | |||
|---|---|---|---|---|---|---|---|---|---|
All (n) | Men (n) | Women (n) | Men (n) | Women (n) | |||||
Attizzani | 2015 | Italy | 2008.08–2013.12 | 171 | 106 | 65 | 30d,12 m | 70.29 ± 10.32 | 74.02 ± 8.51 |
Rodrigo | 2015 | US | 2009.08–2012.11 | 173 | 109 | 64 | 30d,6 m | 73.5 ± 10.2 | 78.9 ± 8.8 |
Gafoor | 2016 | Germany | 2008.10–2011.04 | 567 | 362 | 205 | 30d,12 m | 72 ± 10 | 76 ± 8 |
Tigges | 2016 | Germany | 2008.09–2015.04 | 592 | 362 | 230 | 12 m,24 m | 74.4 ± 8.4 | 76 ± 9.2 |
Doshi | 2018 | US | 2012.01–2014.12 | 521 | 302 | 219 | – | 73.3 ± 15 | 72.8 ± 14.1 |
Elbadawi | 2020 | US | 2012–2016 | 10,015 | 5300 | 4715 | – | 76.08 ± 12.095 | 76.30 ± 12.296 |
Muhammad | 2020 | UK | 2010–2017 | 15,264 | 8080 | 7184 | – | – | – |
Werner | 2020 | Germany | 2010.08–2013.07 | 828 | 501 | 327 | 30d,12 m | 74.2 ± 8.5 | 77 ± 8.3 |
BMI | Logistic EuroSCORE | STS score | Hypertension | Diabetes mellitus | Prior PCI | Prior CABG | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Men (n) | Women (n) | Men (n) | Women (n) | Men (n) | Women (n) | Men (n) | Women (n) | Men (n) | Women (n) | Men (n) | Women (n) | Men (n) | Women (n) |
– | – | 7.68 ± 6.5 | 7.98 ± 7.21 | 6.37 ± 6.91 | 6.78 ± 7.13 | 79 | 48 | 36 | 24 | 34 | 20 | – | – |
– | – | 18.3 ± 14.3 | 19.4 ± 16.1 | – | – | 66 | 41 | 28 | 7 | 31 | 10 | 37 | 8 |
26.4 ± 4 | 25.6 ± 5.1 | 22.7 ± 18.1 | 23.6 ± 18.7 | – | – | – | – | – | – | – | – | – | – |
25.8 ± 4.1 | 25 ± 4.9 | – | – | – | – | 254 | 170 | 119 | 45 | 166 | 72 | 146 | 33 |
– | – | – | – | – | – | 207 | 142 | 84 | 53 | – | – | – | – |
– | – | – | – | – | – | 3590 | 3200 | 1430 | 1125 | 1040 | 600 | 1725 | 665 |
– | – | – | – | – | – | 4043 | 3488 | 894 | 700 | 1546 | 895 | 2428 | 939 |
26.7 ± 10.4 | 26.5 ± 15.1 | 24.7 ± 16.9 | 24.2 ± 20.6 | 8.9 ± 8.5 | 7.7 ± 5.6 | 324 | 200 | 139 | 109 | – | – | 158 | 43 |
Prior stroke | Coronary Artery disease | COPD | Renal failure | Atrial Fibrillation | Previous MI | NYHA ≥III | MR ≥ 3 grade | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Men (n) | Women (n) | Men (n) | Women (n) | Men (n) | Women (n) | Men (n) | Women (n) | Men (n) | Women (n) | Men (n) | Women (n) | Men (n) | Women (n) | Men (n) | Women (n) |
8 | 6 | – | – | 23 | 14 | 46 | 36 | 45 | 22 | 45 | 13 | 85 | 54 | 104 | 62 |
12 | 3 | – | – | 15 | 17 | – | – | 50 | 28 | 50 | 13 | 103 | 62 | – | – |
25 | 10 | 264 | 90 | 79 | 28 | 167 | 70 | 246 | 137 | 138 | 43 | 294 | 172 | 355 | 199 |
66 | 28 | 266 | 115 | 79 | 41 | 230 | 105 | 250 | 148 | 145 | 50 | 344 | 214 | 362 | 228 |
– | – | – | – | – | – | – | – | – | – | 40 | 27 | – | – | – | – |
625 | 560 | 3720 | 2525 | – | – | – | – | – | – | – | – | – | – | – | – |
– | – | 5457 | 3696 | – | – | 3470 | 2170 | – | – | – | – | – | – | – | – |
58 | 23 | 250 | 108 | 119 | 65 | – | – | 203 | 151 | 151 | 69 | 430 | 285 | – | – |